Compare DCTH & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCTH | NBY |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.1M | 398.2M |
| IPO Year | 2015 | 2007 |
| Metric | DCTH | NBY |
|---|---|---|
| Price | $9.41 | $1.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | 457.9K | ★ 817.4K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.53 | 35.42 |
| EPS | 0.07 | ★ 0.76 |
| Revenue | N/A | ★ $370,000.00 |
| Revenue This Year | $29.20 | $23.91 |
| Revenue Next Year | $29.54 | $32.05 |
| P/E Ratio | $135.43 | ★ $1.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.12 | $0.43 |
| 52 Week High | $18.23 | $19.95 |
| Indicator | DCTH | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 41.39 |
| Support Level | $8.90 | $0.94 |
| Resistance Level | $10.51 | $1.36 |
| Average True Range (ATR) | 0.42 | 0.21 |
| MACD | 0.06 | 0.15 |
| Stochastic Oscillator | 55.04 | 5.87 |
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.